Global Health Data Exchange - Discover the World's Health Data

Global Burden of Disease Study 2021 (GBD 2021) Bacterial Antimicrobial Resistance Burden Estimates 1990-2021 and Forecasts 2022-2050

Nav

General Info
Provider 
Institute for Health Metrics and Evaluation (IHME)
Geography 
Global
Coverage type 
Global
Time period covered 
01/1990 - 12/2050
Data type
Estimate
Summary 

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset provides annual estimates for age-specific fertility rate (ASFR), total fertility fate (TFR) and live births for 1950-2100. Data sources used to produce the estimates came from 8709 country-years of vital and sample registrations, 1455 surveys and censuses, and 150 other sources.

Get data files

Keywords 
Antibiotics, Bacterial skin diseases, Carbapenem, Cardiovascular and circulatory diseases, Chlamydia, Chloramphenicol, DALYs, Diarrhea, Digestive diseases, Drug resistance, E. coli, Endocarditis, Fluoroquinolone, GAS infection, GBS infection, Gonococcal infections, Haemophilus influenzae infection, Infectious diseases, Invasive nontyphoidal salmonella, Lower respiratory infections, MRSA infection, Meningitis, Meningococcal infection, Mortality, Musculoskeletal diseases, Pathogens, Penicillin, Peritonitis, Salmonella infections, Shigellosis, Streptococcus pneumoniae infection, Tuberculosis, Typhoid and paratyphoid fevers, Urinary tract infections, YLDs, YLLs
Related publications and visualizations 
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
News release: The Lancet: More than 39 million deaths from antibiotic-resistant infections estimated between now and 2050, suggests first global analysis
Q&A video: Antimicrobial resistance is a growing health threat
GHDx Entry last modified on: Sep 17, 2024